tiprankstipranks
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market

Actuate Therapeutics, Inc. (ACTU) Income Statement

Compare
7 Followers

Actuate Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), Actuate Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Actuate Therapeutics, Inc.'s net income was $-5.97M. See Actuate Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00
Operating Expenses
$ 24.97M$ 20.21M
Depreciation and Amortization
$ 272.85K$ 63.61K
EBITDA
$ -24.70M$ -20.14M
Operating Income
$ -24.97M$ -20.21M
Other Income/Expenses
$ 229.21K$ 47.41K
Pretax Income
$ -24.74M$ -20.16M
Net Income
$ -24.74M$ -20.16M
Per Share Metrics
$ ―$ ―
Basic EPS
$ -1.65$ -1.34
Diluted EPS
$ -1.65$ -1.34
Weighted Average Shares Outstanding
15.03M 15.03M
Weighted Average Shares Outstanding (Diluted)
15.03M 15.03M
Currency in USD

Actuate Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis